ONCOZENGE AB

ONCOZENGE AB

Share · SE0015504097 · A2QNQR (XSTO)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ONCOZENGE AB
No Price
Closing Price XSTO 29.04.2026: 6,35 SEK
29.04.2026 07:29
Current Prices from ONCOZENGE AB
ExchangeTickerCurrencyLast TradePriceDaily Change
XSTO: NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
ONCOZ.ST
SEK
29.04.2026 07:29
6,35 SEK
0,18 SEK
+2,92 %
Share Float & Liquidity
Free Float 61,09 %
Shares Float 7,73 M
Shares Outstanding 12,65 M
Company Profile for ONCOZENGE AB Share
OncoZenge AB (publ), a pharmaceutical company, develops healthcare products for cancer supportive care. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of oral mucositis. The company was founded in 2020 and is headquartered in Bromma, Sweden. OncoZenge AB (publ) is a subsidiary of Moberg Pharma AB (publ).

Company Data

Name ONCOZENGE AB
Company OncoZenge AB (publ)
Website https://www.oncozenge.se
Primary Exchange XSTO NASDAQ STOCKHOLM AB
WKN A2QNQR
ISIN SE0015504097
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Stian Kildal
Market Capitalization 78 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address Gustavslundsvagen 34, 167 51 Bromma
IPO Date 2021-02-12

Stock Splits

Date Split
16.02.2021 621:500

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB ONCOZ.ST
Frankfurt 8LY.F
More Shares
Investors who hold ONCOZENGE AB also have the following shares in their portfolio:
NVLIFESTYLE INC
NVLIFESTYLE INC Share
TELA BIO INC
TELA BIO INC Share